Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Patients with OI type 3 received higher doses of calcium and 25(OH)D3 per kilogram of body weight (p < 0.001 in both comparisons).
Source: 2. Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All procedures performed in this study involving human participants were in accordance with the ethical standards of the Ethics Committee of the Medical University of Lodz and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum Osteocalcin in Pediatric Osteogenesis Imperfecta: Impact of Disease Type and Bisphosphonate Therapy
Study design awaiting verification · International Journal of Molecular Sciences · 2025
Original publication title
Serum Osteocalcin in Pediatric Osteogenesis Imperfecta: Impact of Disease Type and Bisphosphonate Therapy
© 2025 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
The aim of this study was to analyze the factors that may influence serum osteocalcin levels in children with osteogenesis imperfecta treated with intravenous sodium pamidronate and to define the role of osteocalcin assessment. The study included 61 patients diagnosed with osteogenesis imperfecta type 1 or 3, aged 2 to 18, hospitalized for intravenous sodium pamidronate administration. A retrospective analysis of medical records was conducted, collecting information on age, sex, body weight, height, the number of long bone fractures throughout life, serum levels of osteocalcin, creatinine, alkaline phosphatase, 25(OH)D3, and DXA BMD z-scores for the L1: L4 spine segment.
The concentration of osteocalcin is higher in patients with osteogenesis imperfecta than the reference ranges for sex and age. Patients diagnosed with type 3 have significantly lower osteocalcin levels compared to patients with type 1. Also, increasing the age-standardized pamidronate cycle rate significantly reduced osteocalcin concentration. The strongest predictor of osteocalcin concentration among the factors studied is the type of osteogenesis imperfecta. L1: L4 BMD value and fracture frequency were unrelated to osteocalcin concentration. Osteocalcin is an important marker of bone formation that should be measured at the beginning of treatment, as its concentration decreases after successive doses of bisphosphonates.
Authors’ abstract
The aim of this study was to analyze the factors that may influence serum osteocalcin levels in children with osteogenesis imperfecta treated with intravenous sodium pamidronate and to define the role of osteocalcin assessment. The study included 61 patients diagnosed with osteogenesis imperfecta type 1 or 3, aged 2 to 18, hospitalized for intravenous sodium pamidronate administration. A retrospective analysis of medical records was conducted, collecting information on age, sex, body weight, height, the number of long bone fractures throughout life, serum levels of osteocalcin, creatinine, alkaline phosphatase, 25(OH)D3, and DXA BMD z-scores for the L1: L4 spine segment.
The concentration of osteocalcin is higher in patients with osteogenesis imperfecta than the reference ranges for sex and age. Patients diagnosed with type 3 have significantly lower osteocalcin levels compared to patients with type 1. Also, increasing the age-standardized pamidronate cycle rate significantly reduced osteocalcin concentration. The strongest predictor of osteocalcin concentration among the factors studied is the type of osteogenesis imperfecta. L1: L4 BMD value and fracture frequency were unrelated to osteocalcin concentration. Osteocalcin is an important marker of bone formation that should be measured at the beginning of treatment, as its concentration decreases after successive doses of bisphosphonates.
Publication and source details
Original title: Serum Osteocalcin in Pediatric Osteogenesis Imperfecta: Impact of Disease Type and Bisphosphonate Therapy
Jakub Krzysztof Nowicki; Elżbieta Jakubowska-Pietkiewicz
International Journal of Molecular Sciences · 2025
* Correspondence: jakub.nowicki@umed.lodz.pl; Tel.: +48-426177718© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Medical University of Lodz503/1-090-02/503-11-001This study was funded by the Medical University of Lodz: 503/1-090-02/503-11-001.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:16:03.822968+00:00
DOI: 10.3390/ijms26167953 · PMC12386549